The new mineralocorticoid (aldosterone) receptor antagonist eplereone is functioning when a:
I Decrease in blood volume is noted
II decrease in urine potassium is noted
III decrease in urine volume is noted
A I only
B I and II only
C III only
D I, II, III
So Aldosterone is produced when blood volume is low and Blood Na is low (Urine K low) and urine volume is high
So the antagonist should be used when it the opposite condition happens
EK says the answer is B I think they got it backward. Can someone confirm this?
I Decrease in blood volume is noted
II decrease in urine potassium is noted
III decrease in urine volume is noted
A I only
B I and II only
C III only
D I, II, III
So Aldosterone is produced when blood volume is low and Blood Na is low (Urine K low) and urine volume is high
So the antagonist should be used when it the opposite condition happens
EK says the answer is B I think they got it backward. Can someone confirm this?